High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trialResearch in context

High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trialResearch in context

Summary: Background: Difficult airway management remains a critical procedure with life-threatening adverse events. Current guidelines suggest high-flow therapy by nasal cannulae (HFNC) as a preoxygenation device in this setting. However, there is an evidence gap to support this recommendation. Met...

Full description

Bibliographic Details
Main Authors: Mickael Vourc'h, Donatien Huard, Marguerite Le Penndu, Romain Deransy, Marielle Surbled, Maelle Malidin, Pierre-Joachim Mahe, Christophe Guitton, Antoine Roquilly, Olivier Malard, Fanny Feuillet, Bertrand Rozec, Karim Asehnoune
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:EClinicalMedicine
Subjects:
Preoxygenation
High-flow oxygen therapy
Intubation
Fiberoptic intubation
Apnoeic oxygenation
Difficult intubation
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702300175X

Internet

http://www.sciencedirect.com/science/article/pii/S258953702300175X

Similar Items